Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

TomB, I think that your example illustrates both the benefits of an exchange listing, as CTIX proposes, and its subsequent addition to the Russell 2000, as one would reasonably expect, and the pitfalls of failing to provide support to the elevated price with results.

The example was listed on NYSE MKT (vs NASDAQ) on 3/11/14. Price ran from $3.10 on 2/17 to $6.20 on 3/10. On February 11 the company had filed a PR with the headline XX "Files For NYSE MKT Listing and NASDAQ Capital Market Listing"

After that $6.20 reaction to the listing the stock dropped down to $2.16 5 weeks later. The price rose to $3.05 on the date that Russell measures market caps, which was enough (not by much) to get them onto the Russell 2000 index. Between that date and the final date on which their addition to the index was announced the stock rose to $3.42.
Today it's $.82. So your 70% drop has turned into a 76% drop.

Providing some evidence for your point:
"Bottom line is the market doesn't like promising science- they want results and revenue"

Except that isn't quite the way I would put it. I think there's plenty of evidence that the market does like promising science....but at some point it needs to see results and revenue. Exchange listings and Index additions will only take a share price so far, whether that be CTIX's or any other company's.